The global intracranial pressure monitoring market is projected to be valued at over US$ 3.19 billion by the end of 2033. It is expected to record a compound annual growth rate (CAGR) of over 6% during the forecast period, from 2025 to 2033.
There has been an increase in the number of neurological disorder cases which is stimulating the brain monitoring devices market to flourish. Intracranial Pressure (ICP) monitor is a device which is placed inside the brain and is used for measuring brain pressure. It senses the pressure inside the skull and then sends those recorded pressures to the recorder to obtain a better analysis. ICP test is performed in cases where the patient is suffering from a severe head injury or in case of a brain or nervous disease. Monitoring intracranial pressure is very crucial because it can help prevent neurological damage and even death. Therefore, healthcare systems have made it mandatory to have a continuous intracranial pressure monitoring of patients. Due to such cases of trauma and neurological disorders and also due to the rising prevalence of brain disorders, in general, has resulted in the growth of ICP device market. Additionally, a rise in cases of meningitis, brain infection, aneurysm across the world will also increase ICP monitoring requirement thus boosting the ICP monitoring device market. All these factors will lead to a rise in market growth rate during the forecast period.
Global Intracranial Pressure Monitoring Market Segmentation:
By Technique
By Application
- Traumatic Brain Injury
- Intracerebral Hemorrhage
- Meningitis
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Medical Research Institutes
By Region
- Europe
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
North America currently dominates the ICP monitoring market, attributed to its well-established healthcare infrastructure, favorable reimbursement policies, and high adoption rates of advanced medical technologies. Europe follows closely, driven by increased awareness and investment in neurocritical care.
The Asia-Pacific region is poised for significant growth, propelled by rising healthcare expenditures, expanding medical infrastructure, and a growing patient population. Countries like India, China, and Japan are witnessing increased demand for ICP monitoring devices, presenting lucrative opportunities for market players.
Major players included in the Intracranial Pressure Monitoring Market:
- Covidien Ltd.
- Vittamed
- Spiegelberg
- Depuy Synthes
- Sophysa
- Natus Medical, Inc.
- Medtronic plc
- RAUMEDIC AG
- Codman & Shurtleff Inc.
- Orsan Medical Technologies
Natus Medical Incorporated completed the acquisition of Micromed Holding SAS in January 2023, enhancing its capabilities in the neurophysiology market and expanding its offerings in ICP monitoring solutions.
Medtronic plc launched the Camino® IQ system in 2023, a wireless, implantable ICP monitor that enhances real-time data capture and reduces infection risk.
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide an exhaustive analysis on the global intracranial pressure monitoring Market By Technique, By Application, By End User and By Region
• To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
• To record, evaluate, and competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com